• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Pro-ficiency | Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • MedChem Designer™
      • Pro-ficiency Performance Management
      • Panorama KOL Insights Engine
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Pro-ficiency | Adaptive Learning Insights (ALI)
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Pro-ficiency | Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
Simulations Plus Launches Biorelevant Solubility Database
View More
Simulations Plus Launches Biorelevant Solubility Database
  • January 21, 2010
  • Press Release

Simulations Plus Launches Biorelevant Solubility Database

Keywords: biorelevant solubilities, drug solubility, fasted state simulated gastric fluid, fasted state simulated intestinal fluid, fed state simulated intestinal fluid, in vivo
Division: PBPK

Proprietary Data Generated by Company Provides Unique Insight Needed By Drug Developers

  • Read More
Simulations Plus Announces Renewed Share Repurchase Program
  • January 20, 2010
  • Press Release

Simulations Plus Announces Renewed Share Repurchase Program

Keywords: investor relations
Division: PBPK

Up to One Million Shares over 12 Months Authorized by Board of Directors

  • Read More
Simulations Plus Reports First Quarter FY2010 Financial Results
  • January 13, 2010
  • Press Release

Simulations Plus Reports First Quarter FY2010 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Record First Quarter Sees Pharmaceutical Software and Services Revenues Jump 21%, Consolidated Earnings Up 38% from 1QFY09

  • Read More
Simulations Plus Sets Date for 1st Quarter Fiscal Year 2010 Earnings Release and Conference Call
  • January 12, 2010
  • Press Release

Simulations Plus Sets Date for 1st Quarter Fiscal Year 2010 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK
  • Read More
Simulations Plus Appoints John DiBella, M.S., Manager, Marketing and Sales
  • December 16, 2009
  • Press Release

Simulations Plus Appoints John DiBella, M.S., Manager, Marketing and Sales

Keywords: investor relations, John DiBella, marketing and sales

New Leadership Brings Strength in Science and Engineering

  • Read More
Simulations Plus Appoints Robert D. Clark, PH. D., Director of Life Sciences
  • December 10, 2009
  • Press Release

Simulations Plus Appoints Robert D. Clark, PH. D., Director of Life Sciences

Keywords: chemistry, life sciences, pharmaceutical
Division: PBPK

Dr. Clark to Join Team in January

  • Read More
Simulations Plus Launches Abbreviate!™ for the iPhone™
  • December 4, 2009
  • Press Release

Simulations Plus Launches Abbreviate!™ for the iPhone™

Keywords: Abbreviate!, iPhone, iPod Touch, medical transcriptions, Words+
Division: PBPK

New Software Speeds Up Typing on the PopularApple® iPhoneTM and iPod Touch®

  • Read More
Simulations Plus Reports FY2009 Financial Results
  • November 30, 2009
  • Press Release

Simulations Plus Reports FY2009 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Sales up 2% to $9.143 Million, Cash up 26.9%, Earnings $0.08 Per Fully Diluted Share

  • Read More
Simulations Plus Sets Date for Fiscal Year 2009 Earnings Release and Conference Call
  • November 27, 2009
  • Press Release

Simulations Plus Sets Date for Fiscal Year 2009 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to Be on Monday, November 30, at 4:15 PM EST

  • Read More
Simulations Plus Releases GastroPlus Version 6.1
  • November 25, 2009
  • Press Release

Simulations Plus Releases GastroPlus Version 6.1

Keywords: intravenous dosing, oral absorption, oral cavity, pharmacodynamics, pharmacokinetics
Software: GastroPlus®
Division: PBPK

Flagship Product Features New Routes of Administration & Numerous User Conveniences

  • Read More
Simulations Plus Releases ClassPharmer Version 4.7
  • October 13, 2009
  • Press Release

Simulations Plus Releases ClassPharmer Version 4.7

Keywords: cheminformatics, drug absorption, in silico, molecular structure, pharmacokinetics
Division: PBPK

Numerous Data Mining and Drug Design Capabilities Added

  • Read More
Simulations Plus Announces Extension of Share Repurchase Program
  • August 21, 2009
  • Press Release

Simulations Plus Announces Extension of Share Repurchase Program

Keywords: investor relations
Division: PBPK
  • Read More
Simulations Plus Subsidiary Receives Medicare Accreditation
  • August 17, 2009
  • Press Release

Simulations Plus Subsidiary Receives Medicare Accreditation

Keywords: Medicare, wholly owned subsidiary, Words+
Division: PBPK

Highest level of accreditation achieved after on-site inspection

  • Read More
Simulations Plus CEO to Present at Southern California Investor Conference
  • August 14, 2009
  • Press Release

Simulations Plus CEO to Present at Southern California Investor Conference

Keywords: investor relations, Southern California Investor Conference
Division: PBPK

Presentation to be Webcast

  • Read More
U.S. FDA Expands GastroPlus™ Software Licenses
  • August 10, 2009
  • Press Release

U.S. FDA Expands GastroPlus™ Software Licenses

Keywords: absorption, dissolution, FDA Office of Generic Drugs, pharmacokinetics, The U.S. Food and Drug Administration
Software: GastroPlus®
Division: PBPK
  • Read More
Simulations Plus Releases ADMET Predictor™ Version 4.0
  • July 21, 2009
  • Press Release

Simulations Plus Releases ADMET Predictor™ Version 4.0

Keywords: cheminformatics, metabolism, molecular property prediction program, Small Business Innovation Research (SBIR), solubility
Software: ADMET Predictor®
Division: PBPK

Latest Update to Best-in-Class Software Further Extends Lead over Competition

  • Read More
Simulations Plus Reports Third Quarter FY2009 Financial Results
  • July 16, 2009
  • Press Release

Simulations Plus Reports Third Quarter FY2009 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Best-in-Class Pharmaceutical Software & Services Sales Remain Strong

  • Read More
Simulations Plus Sets Date for Third Quarter Fiscal Year 2009 Earnings Release and Conference Call
  • July 15, 2009
  • Press Release

Simulations Plus Sets Date for Third Quarter Fiscal Year 2009 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to Be on Thursday, July 16, at 4:15 PM EDT

  • Read More
Simulations Plus Named to Fortune Small Business FSB 100 List
  • July 7, 2009
  • Press Release

Simulations Plus Named to Fortune Small Business FSB 100 List

Keywords: Fortune Small Business, investor relations
Division: PBPK
  • Read More
Simulations Plus Reports Preliminary Results for Third Fiscal Quarter
  • June 2, 2009
  • Press Release

Simulations Plus Reports Preliminary Results for Third Fiscal Quarter

Keywords: financial results, investor relations
Division: PBPK

Company CEO to Present at New York City Investor Meeting and Webinar

  • Read More
  • «
  • 1
  • 2
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • »
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • MedChem Designer™
  • QSP Software
  • Pro-ficiency Performance Management
  • Panorama KOL Insights Engine
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Pro-ficiency | Adaptive Learning & Insights (ALI)
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept